Are you Dr. Kennedy?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 85 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1100 Walnut St
MOB 5TH floor
Philadelphia, PA 19107Phone+1 215-955-6750Fax+1 215-923-8222
Summary
- Dr. Eugene Kennedy, MD is a general surgeon in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania, Louisiana, and Maryland. He is affiliated with Thomas Jefferson University Hospital.
Education & Training
- Johns Hopkins UniversityResidency, Surgery, 1996 - 2004
- Virginia Commonwealth University School of MedicineClass of 1996
Certifications & Licensure
- PA State Medical License 2005 - 2024
- MD State Medical License 1999 - 2008
- LA State Medical License 2005 - 2007
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy Start of enrollment: 2006 May 25
- Intraoperative Celiac Plexus Neurolysis for Patients With Operable Pancreatic and Periampullary Cancer Start of enrollment: 2008 Sep 01
- An Evaluation of a New Technique Utilizing a Biologic Glue and Tissue Patch to Seal the Cut Edge of the Pancreas Following Removal of the Tail of the Pancreas Start of enrollment: 2008 Aug 01
Publications & Presentations
PubMed
- 46 citationsInhibition of the BTK-IDO-mTOR axis promotes differentiation of monocyte-lineage dendritic cells and enhances anti-tumor T cell immunityMadhav D. Sharma, Rafal Pacholczyk, Huidong Shi, Zuzana Berrong, Yousef Zakharia
Immunity. 2021-10-12 - 49 citationsPhase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma.Yousef Zakharia, Robert R. McWilliams, Olivier Rixe, Joseph J. Drabick, Montaser Shaheen
Journal for Immunotherapy of Cancer. 2021-06-11 - 27 citationsEffect of Taxane Chemotherapy With or Without Indoximod in Metastatic Breast Cancer: A Randomized Clinical Trial.Veronica Mariotti, Hyo S. Han, Roohi Ismail-Khan, Shou-Ching Tang, Patrick M. Dillon
JAMA Oncology. 2021-01-01
Press Mentions
- Summary of NewLink Genetics Corporation (NASDAQ:NLNK) Ratings as of Dec 17, 2018December 17th, 2018
- Update Confirms Benefit of Pembrolizumab plus Indoximod in MelanomaSeptember 7th, 2017
Professional Memberships
- Member
- Member